Tag

Dr Korendowych is a Consultant Rheumatologist and Clinical Lead for Rheumatology at the Royal National Hospital for Rheumatic Diseases in Bath. She undertook her medical training at Cambridge and Oxford Universities. She was appointed as a Consultant at the RNHRD in Bath in 2005. She became Clinical Lead for the Rheumatology Unit in 2007 and was appointed as Medical Director of the RNHRD in 2014. Dr Korendowych’s main clinical and research interests are in Psoriatic Arthritis (PsA) and the Autoimmune Connective Tissue Disorders especially Lupus.

Dr Korendowych was awarded an Arthritis Research Campaign Travelling Fellowship to undertake a PhD in Australia in 2001-2003. In 2004 she was awarded her PhD by the University of Bath for ‘An Immunogenetic Study of Psoriatic Arthritis’. She has published widely on PsA and has led national workshops on the clinical assessment of PsA. She is a member of the International Consortium of experts in PsA known as GRAPPA (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis). She is a member and former Steering Group founding member of PAGE (PsA Genetics European Consortium) which facilitates collaborative research across Europe into the Genetics of PsA. She is a founder member of BRIT-PACT (British PsA Consortium). She is a medical advisor for the Psoriasis and Psoriatic Arthritis Alliance. She undertakes Clinical trials in PsA and contributes to a number of non-commercial research programmes at the RNHRD in Bath on outcome measures, genetics, biomarkers and biologics in PsA. She is the National Expert for NICE appraisals for biologics in PsA for the British Society of Rheumatology. In 2007, she established one of the first dedicated PsA biologics clinics in the country which attracts referrals from around the UK. Her main areas of expertise are in biologic therapy, outcome measures and assessment, co-morbidities and the immunogenetics of PsA.

Dr Korendowych also leads the Lupus service at the RNHRD and developed a dedicated Lupus clinic to assess outcome measures and co-morbidities in patients with Lupus. In 2015, Dr Korendowych and her team were recognised as a Lupus Centre of Excellence by Lupus UK.